The respiratory segment, often influenced by seasonal factors, registered a 1.1% increase in value but faced a 4.6% decline ...

This came after Zydus Lifesciences presented a bioequivalence study report ... She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

stated that Zydus aims to globalize its medical device business, with a current focus on orthopedic implants, cardiology, and nephrology. Describing the medical device sector as a "sunrise sector ...

The government has recognised the medical device sector as a sunrise sector with strong growth potential, it stated. Zydus MedTech is focusing on high quality products and solutions for patients ...

March 11 (Reuters) - India's Zydus Lifesciences (ZYDU.NS), opens new ... as part of its plans to expand further in the global medical devices market. The acquisition, which is a nearly 81% premium ...

Zydus sees significant opportunity for growth of the medical devices, both domestically and overseas, and is eyeing three segments—orthopaedics, interventional cardiology and nephrology.

(Reuters) -India's Zydus Lifesciences (ZYDUSLIFE.NS) said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA) for 256.8 million euros (nearly $280 million) as part of ...

Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., said: “We believe this was a natural extension in the field of medical technology. In Amplitude Surgical, we see several medium-term ...